Anebulo Pharmaceuticals Inc
F:214
Anebulo Pharmaceuticals Inc
F:214
Price:
0.745
EUR
Market Cap:
€19.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Anebulo Pharmaceuticals Inc
F:214
|
US |
|
Total Transport Systems Ltd
NSE:TOTAL
|
IN |
|
S
|
Sofiva Genomics Co Ltd
TPEX:6615
|
TW |
|
G
|
Gigastorage Corp
TWSE:2406
|
TW |
|
EPH European Property Holdings Ltd
F:E6P
|
VG |
|
First Capital Inc
NASDAQ:FCAP
|
US |
|
Pyrophyte Acquisition Corp II
NYSE:PAII
|
US |
|
Zueblin Immobilien Holding AG
SIX:ZUBN
|
CH |
|
Manzo Pharmaceuticals Inc
OTC:MNZO
|
CA |
|
E
|
Entire Technology Co Ltd
TPEX:6775
|
TW |
|
G
|
Glarner Kantonalbank
F:GLR
|
CH |
|
Fesh Fash Snack Food Production Co
SAU:9515
|
SA |
|
Thomson Medical Group Ltd
SGX:A50
|
SG |
|
P
|
Peptron Inc
KOSDAQ:087010
|
KR |
|
Keyera Corp
TSX:KEY
|
CA |
|
Smoove PLC
LSE:SMV
|
UK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Anebulo Pharmaceuticals Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
Not Available
